» Articles » PMID: 37132100

Generalized Low Levels of Serum N-glycans Associate with Better Health Status

Overview
Journal Aging Cell
Specialties Cell Biology
Geriatrics
Date 2023 May 3
PMID 37132100
Authors
Affiliations
Soon will be listed here.
Abstract

Caloric restriction (CR) can prolong life and ameliorate age-related diseases; thus, its molecular basis might provide new insights for finding biomarker and intervention for aging and age-related disease. Glycosylation is an important post-translational modification, which can timely reflect the changes of intracellular state. Serum N-glycosylation was found changed with aging in humans and mice. CR is widely accepted as an effective anti-aging intervention in mice and could affect mouse serum fucosylated N-glycans. However, the effect of CR on the level of global N-glycans remains unknown. In order to explore whether CR affect the level of global N-glycans, we performed a comprehensive serum glycome profiling in mice of 30% calorie restriction group and ad libitum group at 7 time points across 60 weeks by MALDI-TOF-MS. At each time point, the majority of glycans, including galactosylated and high mannose glycans, showed a consistent low level in CR group. Interestingly, O-acetylated sialoglycans presented an upward change different from other derived traits, which is mainly reflected in two biantennary α2,6-linked sialoglycans (H5N4Ge2Ac1, H5N4Ge2Ac2). Liver transcriptome analysis further revealed a decreased transcriptional level of genes involved in N-glycan biosynthesis while increased level of acetyl-CoA production. This finding is consistent with changes in serum N-glycans and O-acetylated sialic acids. Therefore, we provided one possible molecular basis for the beneficial effect of CR from N-glycosylation perspective.

Citing Articles

Recent advances in analytical methods and bioinformatic tools for quantitative glycomics.

Lu J, Guo S, Liu Q, Tursumamat N, Liu S, Wu S Anal Bioanal Chem. 2025; .

PMID: 39948299 DOI: 10.1007/s00216-025-05778-3.


Glycosylation in aging and neurodegenerative diseases.

Zhang W, Chen T, Zhao H, Ren S Acta Biochim Biophys Sin (Shanghai). 2024; 56(8):1208-1220.

PMID: 39225075 PMC: 11466714. DOI: 10.3724/abbs.2024136.


Generalized low levels of serum N-glycans associate with better health status.

Fan J, Sha J, Chang S, Zhao H, Niu X, Gu Y Aging Cell. 2023; 22(7):e13855.

PMID: 37132100 PMC: 10352567. DOI: 10.1111/acel.13855.

References
1.
Taniguchi N, Kizuka Y . Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res. 2015; 126:11-51. DOI: 10.1016/bs.acr.2014.11.001. View

2.
Bull C, Stoel M, den Brok M, Adema G . Sialic acids sweeten a tumor's life. Cancer Res. 2014; 74(12):3199-204. DOI: 10.1158/0008-5472.CAN-14-0728. View

3.
Fan J, Sha J, Chang S, Zhao H, Niu X, Gu Y . Generalized low levels of serum N-glycans associate with better health status. Aging Cell. 2023; 22(7):e13855. PMC: 10352567. DOI: 10.1111/acel.13855. View

4.
Rudman N, Gornik O, Lauc G . Altered N-glycosylation profiles as potential biomarkers and drug targets in diabetes. FEBS Lett. 2019; 593(13):1598-1615. DOI: 10.1002/1873-3468.13495. View

5.
Reiding K, Hipgrave Ederveen A, Rombouts Y, Wuhrer M . Murine Plasma N-Glycosylation Traits Associated with Sex and Strain. J Proteome Res. 2016; 15(10):3489-3499. DOI: 10.1021/acs.jproteome.6b00071. View